CURRENT COMPANIES
Torramics is a medical device company revolutionizing insulin delivery through its proprietary nanoPump technology—powering the world’s smallest, fully disposable insulin patch pump. Engineered for ultra-low power consumption and precise dosing, the device offers up to three days of continuous infusion in a discreet form factor smaller than a coin stack. With core IP rooted in nanofluidics and proven scalability for mass production, Torramics is positioned to disrupt the $20B+ insulin delivery market and expand into adjacent therapeutic categories like GLP-1s and monoclonal antibodies.
Kangaroo is pioneering a stealth-mode platform to support full-term gestation outside the human body—developing an artificial womb capable of nurturing embryos from implantation through to birth. Combining cutting-edge bioengineered fluid environments, umbilical access systems, and advanced fetal monitoring, Kangaroo aims to transform neonatal care and reproductive medicine. With a focus on regulatory readiness and scalable clinical deployment, this breakthrough technology targets markets including preterm birth intervention, high-risk pregnancies, and beyond
Inventia is redefining drug discovery and regenerative medicine through its proprietary 3D bioprinting platform. Using drop-on-demand precision, Inventia creates physiologically relevant human organoids—such as tumor, brain, and pancreatic models—for high-throughput drug screening, enabling faster, more predictive preclinical pipelines. Its second breakthrough platform, LIGŌ, bioprints personalized skin directly onto wounds using a patient’s own cells, offering a revolutionary approach to regenerative wound care. With partnerships including Merck (MSD) and ongoing clinical trials, Inventia is positioned as a category-defining company at the intersection of biofabrication, precision medicine, and therapeutic innovation.
Vertical Oceans is an AI and robotics vertical farming platform for producing shrimp in the US. Shrimp is the largest seafood market category in the world growing to $100B+ by 2030 (growing 6% annually) and ~95% of shrimp consumed in the U.S. is imported from countries in Asia. Vertical Oceans will enable countries to produce shrimp locally, providing same day high quality fresh shrimp at competitive rates, and guranteeing a local supply of shrimp for restaurants and grocery chains.
Vertical Oceans has created a vertical farming platform that is 99.4% autonomous (reducing labor costs and increasing efficiencies) within a warehouse using AI + robotics + bioengineering, which increases shrimp farming productivity by 17x, with 70% less space and energy needed, growing shrimp 3x faster (~40 days to reach jumbo size vs. ~110 days with standard aquaculture ponds), and operating at 65% EBITDA margins.
Swisspod Technologies is redefining high-speed, zero-emission travel with its proprietary, AI-driven propulsion and levitation systems that can operate both in open-air and Hyperloop environments. Founded by two-time SpaceX Hyperloop Pod Competition winner and co-creator of rLoop technology later adopted by Elon Musk’s Boring Company, Swisspod is taking Hyperloop to the next level—making it faster, more cost-efficient, and scalable. With 5 patents covering its drivetrain and passive rail technology, Swisspod offers a modular, infrastructure-light solution capable of moving passengers and freight at record speeds while maintaining carbon neutrality. The company is actively advancing full-scale testing in Switzerland and the USA, with strategic partnerships and feasibility studies already underway across Europe, the Middle East, Asia, and North America
Dexmate AI is building general-purpose mobile humanoid robots designed for real-world deployment in logistics, healthcare, and service environments. Its flagship robot, Vega, combines high-payload dual arms, omni-directional mobility, and edge-level AI compute into a compact, developer-friendly platform with over 10 hours of runtime. Engineered for dexterous manipulation and teleoperation, Vega is built to handle complex tasks with adaptability and efficiency. Backed by a founding team from MIT, CMU, and UCSD, Dexmate is positioned to lead the commercialization of humanoid robotics with strong early demand and a modular, scalable approach to intelligent automation.